Milestone Scientific (MLSS)

$1.75 0.02 (1.16%)

20:00 EDT MLSS Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap 58.57M

PE Ratio -8.75

EPS -0.2

Volume (Avg. Vol.) 118,100

Day's Range 1.69 - 1.77

52-Week Range 0.85 - 3.05

Dividend & Yield N/A (N/A)

MLSS Stock Predictions, Articles, and Milestone Scientific News

From the Web

Premier selects Milestone Scientific's technologies (NYSEMKT:MLSS)

From Seeking Alpha Oct 13, 2020

Milestone Scientific (MLSS +0.6%) has been awarded group purchasing agreement with Premier for the CompuFlo Epidural System and CathCheck.CompuFlo Epidural System are reportedly backed by extensive published clinical data demonstrating significant reductions in epidural punctures and complication rates. CathCheck technology has the potential to transform the administration of epidural procedures and subsequent monitoring of catheter placement.Effective Nov.

The MicroCap Rodeo Best Ideas Bowl 2020; October 13-16, 2020

From MicroCap Rodeo Oct 8, 2020

NEW YORK, NY / ACCESSWIRE / October 8, 2020 / The MicroCap Rodeo continues this year with its first virtual event set for October 13-16, 2020. This year' "Best Ideas" conference focuses solely on 25 public companies recommended by institutional investors and qualified individual investors. The event will feature 2 days of company presentations followed by 2 days of pre-scheduled 1-1's. This year's event is sponsored by

Milestone Scientific to Present at MicroCap Rodeo Best Ideas Bowl on October 13th

From Milestone Scientific Inc. Oct 7, 2020

ROSELAND, NJ / ACCESSWIRE / October 7, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug instruments that provide painless and precise injections, today announced that it will be presenting at the MicroCap Rodeo Best Ideas Bowl, which is being held virtually on October 13th - 16th, 2020. Leonard Osser, Interim Chief Executive Officer, is scheduled to present on Tuesday, October 13th at 2:30 p.m.,

Milestone Scientific to Hold Investor Webinar and Q&A Session with CEO on September 14

From Milestone Scientific, Inc. Sep 10, 2020

ROSELAND, NJ / ACCESSWIRE / September 10, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides painless and precise injections, today announced that Leonard Osser, Interim Chief Executive Officer, will share insight into the company's recent developments and upcoming milestones during an investor webinar on Monday, September 14, 2020 at 4:00 p.m. ET. A live Q&A

Milestone Scientific Reports Increasing Dental Sales and Robust Pipeline for CompuFlo(R) Epidural System and CathCheck(TM)

From Milestone Scientific, Inc. Sep 9, 2020

Anticipates Q3 2020 dental revenue to increase at least four-fold versus Q2 2020 Reports continued growth in active trials of CompuFlo® Epidural System at premier hospitals ROSELAND, NJ / ACCESSWIRE / September 9, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update regarding the

Milestone Scientific Promotes Arjan Haverhals to President of Milestone Scientific

From Milestone Scientific, Inc. Sep 1, 2020

ROSELAND, NJ / ACCESSWIRE / September 1, 2020 / Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has promoted Jan Adriaan (Arjan) Haverhals to President of Milestone Scientific, replacing Brent Johnston. Mr. Haverhals will continue to serve as President and Chief Executive Officer of the Company's Wand Dental,

Navellier Ratings

Powered by Portfolio Grader

Total Grade

B

Buy